116 related articles for article (PubMed ID: 9744567)
1. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. III. The formation of aurocyanide by myeloperoxidase.
Graham GG; Kettle AJ
Biochem Pharmacol; 1998 Aug; 56(3):307-12. PubMed ID: 9744567
[TBL] [Abstract][Full Text] [Related]
2. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--II. Evidence for the formation and biological activity of aurocyanide.
Graham GG; Dale MM
Biochem Pharmacol; 1990 Jun; 39(11):1697-702. PubMed ID: 2160818
[TBL] [Abstract][Full Text] [Related]
3. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--I. The effects of aurocyanide on the oxidative burst of polymorphonuclear leukocytes.
Rudkowski R; Graham GG; Champion GD; Ziegler JB
Biochem Pharmacol; 1990 Jun; 39(11):1687-95. PubMed ID: 2160817
[TBL] [Abstract][Full Text] [Related]
4. Is local biotransformation the key to understanding the pharmacological activity of salicylates and gold drugs?
Whitehouse MW; Graham GG
Inflamm Res; 1996 Dec; 45(12):579-82. PubMed ID: 8988401
[TBL] [Abstract][Full Text] [Related]
5. The effect of cyanide on the uptake of gold by red blood cells.
Graham GG; Haavisto TM; Jones HM; Champion GD
Biochem Pharmacol; 1984 Apr; 33(8):1257-62. PubMed ID: 6424684
[TBL] [Abstract][Full Text] [Related]
6. Aurocyanide, dicyano-aurate (I), a pharmacologically active metabolite of medicinal gold complexes.
Graham GG; Whitehouse MW; Bushell GR
Inflammopharmacology; 2008 Jun; 16(3):126-32. PubMed ID: 18521543
[TBL] [Abstract][Full Text] [Related]
7. The cellular metabolism and effects of gold complexes.
Graham GG; Champion GD; Ziegler JB
Met Based Drugs; 1994; 1(5-6):395-404. PubMed ID: 18476258
[TBL] [Abstract][Full Text] [Related]
8. 1H, 13C NMR, and electronic absorption spectroscopic studies of the interaction of cyanide with aurothiomalate.
Graham GG; Bales JR; Grootveld MC; Sadler PJ
J Inorg Biochem; 1985 Nov; 25(3):163-73. PubMed ID: 3934340
[TBL] [Abstract][Full Text] [Related]
9. A kinetic study of the reaction between human myeloperoxidase, hydroperoxides and cyanide. Inhibition by chloride and thiocyanate.
Bolscher BG; Wever R
Biochim Biophys Acta; 1984 Jul; 788(1):1-10. PubMed ID: 6331509
[TBL] [Abstract][Full Text] [Related]
10. Thiocyanate and chloride as competing substrates for myeloperoxidase.
van Dalen CJ; Whitehouse MW; Winterbourn CC; Kettle AJ
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):487-92. PubMed ID: 9359420
[TBL] [Abstract][Full Text] [Related]
11. Substrates and products of eosinophil peroxidase.
van Dalen CJ; Kettle AJ
Biochem J; 2001 Aug; 358(Pt 1):233-9. PubMed ID: 11485572
[TBL] [Abstract][Full Text] [Related]
12. Bromination and chlorination reactions of myeloperoxidase at physiological concentrations of bromide and chloride.
Senthilmohan R; Kettle AJ
Arch Biochem Biophys; 2006 Jan; 445(2):235-44. PubMed ID: 16125131
[TBL] [Abstract][Full Text] [Related]
13. Superoxide is an antagonist of antiinflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase.
Kettle AJ; Gedye CA; Winterbourn CC
Biochem Pharmacol; 1993 May; 45(10):2003-10. PubMed ID: 8390258
[TBL] [Abstract][Full Text] [Related]
14. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation.
Weiss SJ; Klein R; Slivka A; Wei M
J Clin Invest; 1982 Sep; 70(3):598-607. PubMed ID: 6286728
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide.
Kettle AJ; Gedye CA; Winterbourn CC
Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):503-8. PubMed ID: 9020887
[TBL] [Abstract][Full Text] [Related]
16. Gold complexes and activation of human polymorphonuclear leukocytes. Dissociation of changes in membrane potential and oxidative burst.
Rudkowski R; Ziegler JB; Graham GG; Joulianos G
Biochem Pharmacol; 1992 Sep; 44(6):1091-8. PubMed ID: 1417933
[TBL] [Abstract][Full Text] [Related]
17. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation.
Anderson MM; Hazen SL; Hsu FF; Heinecke JW
J Clin Invest; 1997 Feb; 99(3):424-32. PubMed ID: 9022075
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen cyanide and cyanogen chloride formation by the myeloperoxidase-H2O2-Cl- system.
Zgiczyński JM; Stelmaszyńska T
Biochim Biophys Acta; 1979 Apr; 567(2):309-14. PubMed ID: 36154
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of myeloperoxidase-dependent chlorination of monochlorodimedon.
Kettle AJ; Winterbourn CC
Biochim Biophys Acta; 1988 Nov; 957(2):185-91. PubMed ID: 2847800
[TBL] [Abstract][Full Text] [Related]
20. New insights into thiocyanate oxidation by human myeloperoxidase.
Schlorke D; Flemmig J; Gau J; Furtmüller PG; Obinger C; Arnhold J
J Inorg Biochem; 2016 Sep; 162():117-126. PubMed ID: 27343172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
